(Q72667215)
Statements
Prognostic factors of the clinical response to subcutaneous immunotherapy with interleukin-2 alone in patients with metastatic renal cell carcinoma (English)
P Lissoni
S Barni
A Ardizzoia
S Crispino
F Paolorossi
M Andres
E Scardino